21.68
price down icon1.54%   -0.34
 
loading
Avantor Inc. stock is currently priced at $21.68, with a 24-hour trading volume of 5.80M. It has seen a -1.54% decreased in the last 24 hours and a -13.66% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $21.98 pivot point. If it approaches the $21.45 support level, significant changes may occur.
Previous Close:
$22.02
Open:
$21.88
24h Volume:
5.80M
Market Cap:
$14.73B
Revenue:
$6.87B
Net Income/Loss:
$260.00M
P/E Ratio:
40.15
EPS:
0.54
Net Cash Flow:
$639.00M
1W Performance:
-9.70%
1M Performance:
-13.66%
6M Performance:
-3.30%
1Y Performance:
+10.84%
1D Range:
Value
$21.44
$22.00
52W Range:
Value
$16.63
$26.16

Avantor Inc. Stock (AVTR) Company Profile

Name
Name
Avantor Inc.
Name
Phone
610-386-1700
Name
Address
Radnor Corporate Center, Building One Suite 200 100 Matsonford Road, Radnor, PA
Name
Employee
12,000
Name
Twitter
@Avantor_News
Name
Next Earnings Date
2024-05-30
Name
Latest SEC Filings
Name
AVTR's Discussions on Twitter

Avantor Inc. Stock (AVTR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-04-24 Upgrade Evercore ISI In-line → Outperform
Dec-11-23 Upgrade TD Cowen Market Perform → Outperform
Sep-28-23 Initiated Bernstein Mkt Perform
Jul-31-23 Downgrade Evercore ISI Outperform → In-line
Jul-31-23 Downgrade William Blair Outperform → Mkt Perform
Jun-21-23 Initiated RBC Capital Mkts Outperform
Dec-14-22 Initiated Deutsche Bank Hold
Oct-05-22 Upgrade Citigroup Neutral → Buy
Sep-14-22 Downgrade Cowen Outperform → Market Perform
Sep-09-22 Downgrade Cleveland Research Buy → Neutral
Aug-25-22 Initiated Credit Suisse Neutral
Apr-04-22 Downgrade Citigroup Buy → Neutral
Oct-15-21 Resumed Cowen Outperform
Aug-30-21 Resumed Raymond James Outperform
Aug-05-21 Resumed Credit Suisse Outperform
Aug-02-21 Upgrade Piper Sandler Neutral → Overweight
Jun-04-21 Initiated Goldman Buy
Apr-29-21 Upgrade Stifel Hold → Buy
Mar-03-21 Initiated Barclays Overweight
Nov-10-20 Initiated KeyBanc Capital Markets Overweight
Sep-14-20 Initiated Morgan Stanley Overweight
Jul-15-20 Upgrade Cleveland Research Neutral → Buy
Jan-08-20 Initiated Wells Fargo Overweight
Jan-07-20 Initiated Citigroup Buy
Nov-15-19 Initiated Stifel Hold
Aug-02-19 Initiated Cleveland Research Neutral
Jun-14-19 Initiated Janney Buy
Jun-12-19 Initiated Raymond James Outperform
Jun-11-19 Initiated Goldman Buy
Jun-11-19 Initiated Guggenheim Buy
Jun-11-19 Initiated JP Morgan Overweight
Jun-11-19 Initiated Jefferies Buy
Jun-11-19 Initiated KeyBanc Capital Markets Sector Weight
Jun-11-19 Initiated Piper Jaffray Neutral
Jun-11-19 Initiated RBC Capital Mkts Outperform
Jun-11-19 Initiated Robert W. Baird Outperform
Jun-11-19 Initiated SunTrust Buy
Jun-11-19 Initiated UBS Buy
Jun-11-19 Initiated William Blair Outperform
View All

Avantor Inc. Stock (AVTR) Financials Data

Avantor Inc. (AVTR) Revenue 2024

AVTR reported a revenue (TTM) of $6.87 billion for the quarter ending March 31, 2024, a -6.48% decline year-over-year.
loading

Avantor Inc. (AVTR) Net Income 2024

AVTR net income (TTM) was $260.00 million for the quarter ending March 31, 2024, a -57.90% decrease year-over-year.
loading

Avantor Inc. (AVTR) Cash Flow 2024

AVTR recorded a free cash flow (TTM) of $639.00 million for the quarter ending March 31, 2024, a -17.44% decrease year-over-year.
loading

Avantor Inc. (AVTR) Earnings per Share 2024

AVTR earnings per share (TTM) was $0.38 for the quarter ending March 31, 2024, a -58.70% decline year-over-year.
loading
Avantor, Inc. develops, customizes, manufactures, and supplies products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, and process chromatography resins and columns, as well as analytical sample prep, education, and microbiology and clinical trial kits. Its equipment and instrumentation products comprise filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and environment supplies. The company also provides onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
specialty_chemicals WLK
$149.83
price down icon 2.21%
specialty_chemicals IFF
$94.54
price down icon 0.55%
specialty_chemicals PPG
$127.32
price down icon 1.90%
specialty_chemicals LYB
$93.54
price down icon 2.11%
specialty_chemicals DD
$79.66
price down icon 0.52%
Cap:     |  Volume (24h):